TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy (NCT00766961) | Clinical Trial Compass
TerminatedNot Applicable
TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy
China34 participantsStarted 2007-04
Plain-language summary
The aim of the study is to compare the outcomes of trans-catheter arterial embolization (TAE) and surgery as salvage therapy of peptic ulcer bleeding after failed endoscopic therapy.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with bleeding peptic ulcers documented during endoscopic therapy AND anyone of the following:
* Forrest I bleeding that fails to be controlled by therapy during first endoscopy
* Check endoscopy after clinical re-bleeding of Forrest I bleeding
* Forrest IIa or an initial IIb but a sizable artery unveiled upon clot elevation in a high risk ulcer defined by:
* posterior bulbar duodenal ulcer \> 2cm, or
* an angular notch / lesser curve gastric ulcer \> 5cm that fail an attempt at endoscopic therapy together with evidence of a significant bleed (hypotension with SBP \< 90mmHg, fresh hematemesis or hematochezia).
Exclusion Criteria:
* Refusal to participate in trial
* No consent
* Age \< 18
* Pregnancy
* Moribund patients
* Patients with terminal malignancy